Table 6.
Parameter | B | Sig | Exp(B) | 95% C.I. for EXP(B) |
---|---|---|---|---|
CEA (continuous) | 0.052 | 0.006 | 1.053 | 1.015–1.093 |
Tumor size (cm) (continuous) | 0.155 | 0.009 | 1.168 | 1.040–1.311 |
No NACT (ref.) | 0.134 | 1 | ||
No response to NACT | 22.897 | 0.999 | 8,788,932,664.350 | 0.000– |
Partial response to NACT | 0.842 | 0.021 | 2.320 | 1.137–4.734 |
Complete response to NACT | − 0.396 | 0.707 | 0.673 | 0.086–5.296 |
ER-negative (ref.) | 0.028 | 1 | ||
ER(+) | − 0.632 | 0.086 | 0.531 | 0.258–1.094 |
ER(++) | − 0.490 | 0.154 | 0.613 | 0.312–1.202 |
ER(+++) | − 0.841 | 0.004 | 0.431 | 0.245–0.759 |
N0 (ref.) | < 0.001 | 1 | ||
N1 | 0.200 | 0.521 | 1.221 | 0.663–2.249 |
N2 | 1.118 | 0.001 | 3.058 | 1.591–5.878 |
N3 | 1.291 | < 0.001 | 3.635 | 1.790–7.379 |
No local recurrence (ref.) | 0.052 | 1 | ||
Recurrence in the opposite breast | 0.578 | 0.316 | 1.782 | 0.575–5.519 |
Locoregional recurrence | 1.283 | 0.024 | 3.609 | 1.188–10.964 |
Constant | − 2.736 | < 0.001 | 0.065 |
NACT neoadjuvant chemotherapy, N nodal involvement.